New study targets diabetes disparities in black patients
Knowledge-focused
Ongoing
This study looks at how two types of FDA-approved diabetes medicines—GLP-1 receptor agonists and SGLT-2 inhibitors—affect the pancreas's ability to make insulin in Black patients with type 2 diabetes. About 60 adults will take one of the drugs for 16 weeks, and researchers will m…
Phase: PHASE4 • Sponsor: MaryAnn Banerji • Aim: Knowledge-focused
Last updated May 04, 2026 16:18 UTC